Drugs / BI 1034020
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01958060 | Oct 2013 → Apr 2014 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 1034020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01958060 ↗ |
| Route | Intravenous | “intravenous (IV) infusion” NCT01958060 ↗ |